Search - tctmd.com

Displaying 561 - 580 of 1438

Sort: Relevancy | Date

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

November 17, 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

November 15, 2020

November 2020 News Roundup

News Opinion CV Team Dispatch

November 2020 News Roundup

November 01, 2020

COVID-19: TCTMD’s Daily Dispatch for November

News

COVID-19: TCTMD’s Daily Dispatch for November

November 01, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

Treating Accessory Arteries May Be Important in Renal Denervation

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

October 18, 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

October 17, 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

October 17, 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

October 16, 2020

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

COVID-19 IMPACT VIEWS From the … - Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presentation TCT 2020

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presenter: Manuela Negoita

October 15, 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

October 14, 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presentation TCT 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presenter: Elvin Kedhi

October 14, 2020

News Industry News

NuVera Medical Announces Positive Results From First-in-human Feasibility Study At 2020 TCT Conference

October 14, 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

October 12, 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

October 09, 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

October 09, 2020

October 2020 News Roundup

News Opinion CV Team Dispatch

October 2020 News Roundup

October 01, 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.